Meggan Valrance

441 total citations
10 papers, 342 citations indexed

About

Meggan Valrance is a scholar working on Pathology and Forensic Medicine, Genetics and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Meggan Valrance has authored 10 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 6 papers in Genetics and 2 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Meggan Valrance's work include Vitamin D Research Studies (9 papers), Estrogen and related hormone effects (6 papers) and Cancer-related Molecular Pathways (2 papers). Meggan Valrance is often cited by papers focused on Vitamin D Research Studies (9 papers), Estrogen and related hormone effects (6 papers) and Cancer-related Molecular Pathways (2 papers). Meggan Valrance collaborates with scholars based in United States, France and Canada. Meggan Valrance's co-authors include JoEllen Welsh, Glendon M. Zinser, Sivanesan Dakshanamurthy, Mahadev Rao, Ana Aranda, JoEllen Welsh, Dino Moras, Anthony W. Norman, Imran Rizvi and Stephen W. Byers and has published in prestigious journals such as Molecular Cell, Endocrinology and Journal of Cellular Biochemistry.

In The Last Decade

Meggan Valrance

10 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meggan Valrance United States 8 208 133 115 69 47 10 342
JoEllen Welsh United States 5 212 1.0× 113 0.8× 111 1.0× 73 1.1× 48 1.0× 6 343
Tim Cordes Germany 15 246 1.2× 114 0.9× 101 0.9× 51 0.7× 45 1.0× 33 463
Wenlong Bai United States 4 99 0.5× 128 1.0× 171 1.5× 55 0.8× 23 0.5× 4 359
Christine Kimmel‐Jehan United States 6 241 1.2× 87 0.7× 99 0.9× 28 0.4× 79 1.7× 8 355
Yanfei Ma United States 6 81 0.4× 56 0.4× 66 0.6× 66 1.0× 27 0.6× 8 247
Zhentao Zhang China 9 114 0.5× 62 0.5× 92 0.8× 45 0.7× 35 0.7× 15 250
Michael A. Pani Germany 9 78 0.4× 106 0.8× 132 1.1× 20 0.3× 26 0.6× 11 329
Von G. Samedi United States 9 97 0.5× 57 0.4× 95 0.8× 106 1.5× 19 0.4× 19 322
Angeline A. Giangreco United States 6 133 0.6× 43 0.3× 195 1.7× 34 0.5× 45 1.0× 7 365
Giovanna Forte Italy 11 80 0.4× 55 0.4× 213 1.9× 92 1.3× 48 1.0× 35 435

Countries citing papers authored by Meggan Valrance

Since Specialization
Citations

This map shows the geographic impact of Meggan Valrance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meggan Valrance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meggan Valrance more than expected).

Fields of papers citing papers by Meggan Valrance

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meggan Valrance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meggan Valrance. The network helps show where Meggan Valrance may publish in the future.

Co-authorship network of co-authors of Meggan Valrance

This figure shows the co-authorship network connecting the top 25 collaborators of Meggan Valrance. A scholar is included among the top collaborators of Meggan Valrance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meggan Valrance. Meggan Valrance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Valrance, Meggan, et al.. (2008). Calcium, Vitamin D and the Vitamin D Receptor: Impact on Prostate and Breast Cancer in Preclinical Models. Nutrition Reviews. 65(8 Pt 2). S131–S133. 15 indexed citations
2.
Valrance, Meggan, et al.. (2007). Dissociation of growth arrest and CYP24 induction by VDR ligands in mammary tumor cells. Journal of Cellular Biochemistry. 101(6). 1505–1519. 11 indexed citations
3.
Valrance, Meggan, et al.. (2007). Calcium, Vitamin D and the Vitamin D Receptor: Impact on Prostate and Breast Cancer in Preclinical Models. Nutrition Reviews. 65(8). 131–133. 13 indexed citations
4.
Valrance, Meggan, et al.. (2007). Vitamin D Receptor-Dependent Inhibition of Mammary Tumor Growth by EB1089 and Ultraviolet Radiation in Vivo. Endocrinology. 148(10). 4887–4894. 40 indexed citations
5.
Shah, Salimuddin, Sivanesan Dakshanamurthy, Imran Rizvi, et al.. (2006). The Molecular Basis of Vitamin D Receptor and β-Catenin Crossregulation. Molecular Cell. 22(1). 148–148. 1 indexed citations
6.
Shah, Salimuddin, Sivanesan Dakshanamurthy, Imran Rizvi, et al.. (2006). The Molecular Basis of Vitamin D Receptor and β-Catenin Crossregulation. Molecular Cell. 21(6). 799–809. 189 indexed citations
7.
Zinser, Glendon M., Emily K. Tribble, Meggan Valrance, et al.. (2005). 1,24(S)-dihydroxyvitamin D2, an endogenous vitamin D2 metabolite, inhibits growth of breast cancer cells and tumors.. PubMed. 25(1A). 235–41. 16 indexed citations
8.
Valrance, Meggan & JoEllen Welsh. (2004). Breast cancer cell regulation by high-dose Vitamin D compounds in the absence of nuclear Vitamin D receptor. The Journal of Steroid Biochemistry and Molecular Biology. 89-90(1-5). 221–225. 27 indexed citations
9.
Valrance, Meggan. (2004). Breast cancer cell regulation by high-dose Vitamin D compounds in the absence of nuclear Vitamin D receptor*1. The Journal of Steroid Biochemistry and Molecular Biology. 1 indexed citations
10.
Narvaez, Carmen J., et al.. (2003). Induction of apoptosis by 1,25-dihydroxyvitamin D3 in MCF-7 Vitamin D3-resistant variant can be sensitized by TPA. The Journal of Steroid Biochemistry and Molecular Biology. 84(2-3). 199–209. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026